Ritonavir and Agenerase Treatment for Patients Who Have Failed Previous Anti-HIV Treatment
Not Applicable
- Conditions
- HIV Infections
- Registration Number
- NCT00006591
- Lead Sponsor
- Gathe, Joseph, M.D.
- Brief Summary
The purpose of this study is to determine if treatment with an anti-HIV drug containing ritonavir and Agenerase is safe and can lower the level of HIV in the blood in patients who have failed an anti-HIV drug treatment containing nelfinavir.
- Detailed Description
HIV-infected patients will be treated with a ritonavir-enhanced Agenerase regimen.
Recruitment & Eligibility
- Status
- UNKNOWN
- Sex
- All
- Target Recruitment
- Not specified
Inclusion Criteria
Not provided
Exclusion Criteria
Not provided
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (1)
Gathe, Joseph, M.D.
🇺🇸Houston, Texas, United States
Gathe, Joseph, M.D.🇺🇸Houston, Texas, United States